GB9519654D0 - Stabilised phospholipid compositions - Google Patents

Stabilised phospholipid compositions

Info

Publication number
GB9519654D0
GB9519654D0 GBGB9519654.9A GB9519654A GB9519654D0 GB 9519654 D0 GB9519654 D0 GB 9519654D0 GB 9519654 A GB9519654 A GB 9519654A GB 9519654 D0 GB9519654 D0 GB 9519654D0
Authority
GB
United Kingdom
Prior art keywords
stabilised
phospholipid compositions
phospholipid
compositions
stabilised phospholipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9519654.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
GE Healthcare AS
Original Assignee
Daiichi Pharmaceutical Co Ltd
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd, Nycomed Imaging AS filed Critical Daiichi Pharmaceutical Co Ltd
Priority to GBGB9519654.9A priority Critical patent/GB9519654D0/en
Publication of GB9519654D0 publication Critical patent/GB9519654D0/en
Priority to CN96198585A priority patent/CN1202830A/en
Priority to CA002233135A priority patent/CA2233135A1/en
Priority to EP96931893A priority patent/EP0857070A2/en
Priority to PCT/GB1996/002364 priority patent/WO1997011683A2/en
Priority to JP09513213A priority patent/JP2000515487A/en
Priority to NO981340A priority patent/NO981340L/en
Priority to US09/982,196 priority patent/US20020039556A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9519654.9A 1995-09-27 1995-09-27 Stabilised phospholipid compositions Pending GB9519654D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9519654.9A GB9519654D0 (en) 1995-09-27 1995-09-27 Stabilised phospholipid compositions
CN96198585A CN1202830A (en) 1995-09-27 1996-09-25 Stabilised phospholipid compositions
CA002233135A CA2233135A1 (en) 1995-09-27 1996-09-25 Stabilised phospholipid compositions
EP96931893A EP0857070A2 (en) 1995-09-27 1996-09-25 Stabilised phospholipid compositions
PCT/GB1996/002364 WO1997011683A2 (en) 1995-09-27 1996-09-25 Stabilised phospholipid compositions
JP09513213A JP2000515487A (en) 1995-09-27 1996-09-25 Stabilized phospholipid composition
NO981340A NO981340L (en) 1995-09-27 1998-03-24 Stabilized phospholipid compositions
US09/982,196 US20020039556A1 (en) 1995-09-27 2001-10-19 Stabilised phospholipid compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9519654.9A GB9519654D0 (en) 1995-09-27 1995-09-27 Stabilised phospholipid compositions

Publications (1)

Publication Number Publication Date
GB9519654D0 true GB9519654D0 (en) 1995-11-29

Family

ID=10781317

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9519654.9A Pending GB9519654D0 (en) 1995-09-27 1995-09-27 Stabilised phospholipid compositions

Country Status (7)

Country Link
EP (1) EP0857070A2 (en)
JP (1) JP2000515487A (en)
CN (1) CN1202830A (en)
CA (1) CA2233135A1 (en)
GB (1) GB9519654D0 (en)
NO (1) NO981340L (en)
WO (1) WO1997011683A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4752987B2 (en) * 2000-10-12 2011-08-17 ライオン株式会社 External preparation composition
WO2007129311A2 (en) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
AU2008343162B2 (en) * 2007-12-20 2012-02-23 Alcon Inc. Method for making contact lenses
JP5299449B2 (en) * 2011-02-23 2013-09-25 ライオン株式会社 External preparation composition
CN104561156B (en) * 2013-10-28 2020-07-07 丰益(上海)生物技术研发中心有限公司 Process for preparing saturated phospholipids
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof
WO2024199424A1 (en) * 2023-03-30 2024-10-03 上海济煜医药科技有限公司 Phospholipid composition, preparation method therefor and use of nitrogen-containing compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US4962022A (en) * 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
ZA902710B (en) * 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
DE69527194T2 (en) * 1994-03-28 2003-02-06 Daiichi Pharmaceutical Co., Ltd. LIPOSOME CONTAINING AN X-RAY OR ULTRASONIC CONTRAST

Also Published As

Publication number Publication date
JP2000515487A (en) 2000-11-21
WO1997011683A2 (en) 1997-04-03
WO1997011683A3 (en) 1997-06-26
NO981340D0 (en) 1998-03-24
CN1202830A (en) 1998-12-23
NO981340L (en) 1998-03-24
CA2233135A1 (en) 1997-04-03
EP0857070A2 (en) 1998-08-12

Similar Documents

Publication Publication Date Title
EG20993A (en) Cleasing compositions
EG20989A (en) Cleasing compositions
GB9508691D0 (en) Stable compositions
GB9613043D0 (en) Improved compositions
GB9506841D0 (en) Deodorant compositions
GB9500577D0 (en) Compositions
ZA967827B (en) Pharmaceutical compositions
EP0848692A4 (en) Improved organoclay compositions
GB9504996D0 (en) Compositions
EG24294A (en) Pharmaceutical compositions
GB9516371D0 (en) Compositions
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
EP0885896A4 (en) Phospholipid composition
GB9519654D0 (en) Stabilised phospholipid compositions
GB9515805D0 (en) Compositions
EP0868430A4 (en) Therapeutic compositions
ZA969209B (en) Insecticidal compositions
GB9604856D0 (en) Compositions
HUP9601550A2 (en) Particulale compositions
GB9519109D0 (en) Compositions
GB2299343B (en) Hydrophobic compositions
GB9526432D0 (en) Stabilised polymer compositions
HU9602732D0 (en) Lanperisone formulation
GB9505604D0 (en) Liposome compositions